| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.4M | +40.9% |
| SG&A Expense | $5.7M | +5.9% |
| Operating Income | -$38.8M | -173.0% |
| Interest Expense | $2K | -50.0% |
| Net Income | -$38.8M | -173.8% |
| EPS (Basic) | -$4.77 | -2881.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.2M | -36.6% |
| Current Assets | $40.2M | -32.3% |
| Total Assets | $40.8M | -48.6% |
| Current Liabilities | $1.2M | -21.3% |
| Total Liabilities | $1.3M | -30.9% |
| Stockholders' Equity | $39.6M | -49.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.4M | -68.5% |
| Capital Expenditures | $74K | +42.3% |
| Investing Cash Flow | -$74K | -42.3% |
| Financing Cash Flow | -$27K | -100.1% |
| Free Cash Flow | -$21.5M | -68.4% |